The nuclear import receptor Kpnß1 and its potential as an anticancer therapeutic target

Critical Reviews in Eukaryotic Gene Expression

Volumn 23, Issue 1, 2013, Pages 1-10

  van der Watt, Pauline J ^a   Stowell, Catherine L ^a   Leaner, Virna D ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cancer; Kpn 1; Nuclear transport; Therapeutic target

Indexed keywords

ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; CELL PROTEIN; EXPORTIN 1; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KARYOPHERIN ALPHA; KARYOPHERIN BETA; KARYOPHERIN BETA 1; LEPTOMYCIN B; MESSENGER RNA; N AZOLYLACRYLATE DERIVATIVE; NUCLEAR FACTOR Y; PARATHYROID HORMONE RELATED PROTEIN; RAS PROTEIN; STAT3 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; DRUG TARGETING; ENERGY TRANSFER; HOMEOSTASIS; HUMAN; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RECEPTOR BINDING; REGULATORY MECHANISM; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

BETA KARYOPHERINS; CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NUCLEAR ENVELOPE; NUCLEAR LOCALIZATION SIGNALS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84875536799     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukarGeneExpr.2013004845     Document Type: Article

References (74)

1. Gorlich D, Kutay U. Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol. 1999;15:607-660.
2. Harel A, Forbes DJ. Importin beta: conducting a much larger cellular symphony. Mol Cell. 2004 Nov 5;16(3):319-330.
3. Fagotto F, Gluck U, Gumbiner BM. Nuclear localization signal-independent and importin/karyopherin-indepen-dent nuclear import of beta-catenin. Curr Biol. 1998 Feb 12;8(4):181-190.
4. Moroianu J. Distinct nuclear import and export pathways mediated by members of the karyopherin beta family. J Cell Biochem. 1998 Aug 1;70(2):231-239.
5. Kutay U, Izaurralde E, Bischoff FR, Mattaj IW, Gorlich D. Dominant-negative mutants of importin-beta block multiple pathways of import and export through the nuclear pore complex. EMBO J. 1997 Mar 17;16(6):1153-1163.
6. Friedrich B, Quensel C, Sommer T, Hartmann E, Kohler M. Nuclear localization signal and protein context both mediate importin alpha specifcity of nuclear import substrates. Mol Cell Biol. 2006 Dec;26(23):8697-8709.
7. Kohler M, Speck C, Christiansen M, Bischoff FR, Prehn S, Haller H, Görlich D, Hartmann E. Evidence for distinct substrate specifcities of importin alpha family members in nuclear protein import. Mol Cell Biol. 1999 Nov;19(11):7782-7791.
8. Lam MH, Briggs LJ, Hu W, Martin TJ, Gillespie MT, Jans DA. Importin beta recognizes parathyroid hormone-related protein with high affnity and mediates its nuclear import in the absence of importin alpha. J Biol Chem. 1999 Mar 12;274(11):7391-7398.
9. Lee SJ, Sekimoto T, Yamashita E, Nagoshi E, Nakaga-wa A, Imamoto N, Yoshimura M, Sakai H, Chong KT, Tsukihara T, Yoneda Y. The structure of importin-beta bound to SREBP-2: nuclear import of a transcription factor. Science. 2003 Nov 28;302(5650):1571-1575.
10. Wychowski C, van der WS, Girard M. Nuclear localization of poliovirus capsid polypeptide VP1 expressed as a fusion protein with SV40-VP1. Gene. 1985;37(1-3):63-71.
11. Dingwall C, Laskey RA. Nuclear targeting sequencesa consensus? Trends Biochem Sci. 1991 Dec;16(12):478-481.
12. Chook YM, Blobel G. Karyopherins and nuclear import. Curr Opin Struct Biol. 2001 Dec;11(6):703-715.
13. Ribbeck K, Lipowsky G, Kent HM, Stewart M, Gorlich D. NTF2 mediates nuclear import of Ran. EMBO J. 1998 Nov 16;17(22):6587-6598.
14. Strom AC, Weis K. Importin-beta-like nuclear transport receptors. Genome Biol. 2001;2(6):REVIEWS3008.
15. Bednenko J, Cingolani G, Gerace L. Importin beta contains a COOH-terminal nucleoporin binding region important for nuclear transport. J Cell Biol. 2003 Aug 4;162(3):391-401.
16. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS,. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 1992 Oct;6(10):1899-1913.
17. Ushijima R, Sakaguchi N, Kano A, Maruyama A, Miyamoto Y, Sekimoto T, Yoneda Y, Ogino K, Tachibana T. Extracellular signal-dependent nuclear import of STAT3 is mediated by various importin alphas. Biochem Bio-phys Res Commun. 2005 May 13;330(3):880-886.
18. Smith ER, Cai KQ, Smedberg JL, Ribeiro MM, Rula ME, Slater C, Godwin AK, Xu XX. Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells. PLoS One. 2010;5(2):e9295.
19. Takizawa CG, Weis K, Morgan DO. Ran-independent nuclear import of cyclin B1-Cdc2 by importin beta. Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7938-7943.
20. Ciciarello M, Mangiacasale R, Thibier C, Guarguaglini G, Marchetti E, Di Fiore B, Lavia P. Importin beta is transported to spindle poles during mitosis and regulates Ran-dependent spindle assembly factors in mammalian cells. J Cell Sci. 2004 Dec 15;117(Pt 26):6511-6522.
21. Harel A, Chan RC, Lachish-Zalait A, Zimmerman E, El-baum M, Forbes DJ. Importin beta negatively regulates nuclear membrane fusion and nuclear pore complex assembly. Mol Biol Cell. 2003 Nov;14(11):4387-4396.
22. Bauerle M, Doenecke D, Albig W. The requirement of H1 histones for a heterodimeric nuclear import receptor. J Biol Chem. 2002 Sep 6;277(36):32480-3249.
23. Pemberton LF, Paschal BM. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffc. 2005 Mar;6(3):187-198.
24. Kodiha M, Chu A, Matusiewicz N, Stochaj U. Multiple mechanisms promote the inhibition of classical nuclear import upon exposure to severe oxidative stress. Cell Death Differ. 2004 Aug;11(8):862-874.
25. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen MB, Brown PO, Botstein D, Futcher B. Comprehensive identifcation of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell. 1998 Dec;9(12):3273-3297.
26. Quan Y, Ji ZL, Wang X, Tartakoff AM, Tao T. Evolutionary and transcriptional analysis of karyopherin beta superfamily proteins. Mol Cell Proteomics. 2008 Jul;7(7):1254-1269.
27. van der Watt PJ, Ngarande E, Leaner VD. Overexpres-sion of Kpnbeta1 and Kpnalpha2 Importin Proteins in Cancer Derives from Deregulated E2F Activity. PLoS One. 2011;6(11):e27723.
28. van der Watt PJ, Leaner VD. The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage. Biochim Biophys Acta. 2011 Jul;1809(7):316-326.
29. Yang W, Musser SM. Nuclear import time and transport effciency depend on importin beta concentration. J Cell Biol. 2006 Sep 25;174(7):951-961.
30. Feldherr C, Cole C, Lanford RE, Akin D. The effects of SV40 large T antigen and p53 on nuclear transport capacity in BALB/c 3T3 cells. Exp Cell Res. 1994 Jul;213(1):164-171.
31. Feldherr CM, Akin D. Signal-mediated nuclear transport in proliferating and growth-arrested BALB/c 3T3 cells. J Cell Biol. 1991 Nov;115(4):933-939.
32. Kuusisto HV, Wagstaff KM, Alvisi G, Roth DM, Jans DA. Global enhancement of nuclear localization-dependent nuclear transport in transformed cells. FASEB. J 2011 Dec 12.
33. Behrens P, Brinkmann U, Fogt F, Wernert N, Wellmann A. Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer Res. 2001 Jul;21(4A):2413-2417.
34. Boni R, Wellmann A, Man YG, Hofbauer G, Brink-mann U. Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions. Am J Dermatopathol. 1999 Apr;21(2):125-128.
35. Brinkmann U. CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer. Am J Hum Genet. 1998 Mar;62(3):509-513.
36. Poon IK, Jans DA. Regulation of nuclear transport: central role in development and transformation? Traffc 2005 Mar;6(3):173-186.
37. Wellmann A, Krenacs L, Fest T, Scherf U, Pastan I, Raffeld M, Brinkmann U. Localization of the cell proliferation and apoptosis-associated CAS protein in lym-phoid neoplasms. Am J Pathol. 1997 Jan;150(1):25-30.
38. Wellmann A, Flemming P, Behrens P, Wuppermann K, Lang H, Oldhafer K, Pastan I, Brinkmann U. High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. Int J Mol Med. 2001 May;7(5):489-494.
39. van der Watt PJ, Maske CP, Hendricks DT, Parker MI, Denny L, Govender D, Birrer MJ, Leaner VD. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int J Cancer. 2009 Apr 15;124(8):1829-1840.
40. Noske A, Weichert W, Niesporek S, Roske A, Buckendahl AC, Koch I, Sehouli J, Dietel M, Denkert C. Expression of the nuclear export protein chromosomal region main-tenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer. Cancer.2008 Apr 15;112(8):1733-1743.
41. Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Chen P, Sun YJ, Tang LN, Zheng SE. The expression of CRM1 is associated with prognosis in human osteosarcoma. Oncol Rep. 2009 Jan;21(1):229-235.
42. Shen A, Wang Y, Zhao Y, Zou L, Sun L, Cheng C. Expression of CRM1 in human gliomas and its signifcance in p27 expression and clinical prognosis. Neurosurgery. 2009 Jul;65(1):153-159.
43. Huang WY, Yue L, Qiu WS, Wang LW, Zhou XH, Sun YJ. Prognostic value of CRM1 in pancreas cancer. Clin Invest Med. 2009;32(6):E315.
44. Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer. Gene expression profling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst. 2006 Apr 5;98(7):472-482.
45. Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, Hermann K, Pilarsky C, Dürst M, Klink-hammer-Schalke M, Blaszyk H, Knuechel R, Hartmann A, Rosenthal A, Wild PJ. Molecular profling of laser-microdissected matched tumor and normal breast tissue identifes karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clin Cancer Res. 2006 Jul 1;12(13):3950-3960.
46. Gluz O, Wild P, Meiler R, allo-Danebrock R, Ting E, Mohrmann S, Schuett G, Dahl E, Fuchs T, Herr A, Gaumann A, Frick M, Poremba C, Nitz UA, Hartmann A. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. Int J Cancer. 2008 Sep 15;123(6):1433-1438.
47. Sakai M, Sohda M, Miyazaki T, Suzuki S, Sano A, Tana-ka N, Inose T, Nakajima M, Kato H, Kuwano H. Significance of karyopherin-{alpha} 2 (KPNA2.expression in esophageal squamous cell carcinoma. Anticancer Res. 2010 Mar;30(3):851-856.
48. Zheng M, Tang L, Huang L, Ding H, Liao WT, Zeng MS, Wang HY. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis. Ob-stet Gynecol. 2010 Oct;116(4):884-891.
49. Wang CI, Wang CL, Wang CW, Chen CD, Wu CC, Liang Y, Tsai YH, Chang YS, Yu JS, Yu CJ. Importin subunit alpha-2 is identifed as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int J Cancer. 2011 May 15;128(10):2364-2372.
50. Mortezavi A, Hermanns T, Seifert HH, Baumgartner MK, Provenzano M, Sulser T, Burger M, Montani M, Ikenberg K, Hofstädter F, Hartmann A, Jaggi R, Moch H, Kristiansen G, Wild PJ. KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res. 2011 Mar 1;17(5):1111-1121.
51. Jensen JB, Munksgaard PP, Sorensen CM, Fristrup N, Birkenkamp-Demtroder K, Ulhoi BP, Jensen KM, Ørn-toft TF, Dyrskjøt L. High expression of karyopherin-alpha2 defnes poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy. Eur Urol. 2011 May;59(5):841-848.
52. Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, Matsumura S, Mitsunori Y, Yasen M, Ban D, Noguchi N, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S. Impor-tin-alpha1 as a novel prognostic target for hepatocellular carcinoma. Ann Surg Oncol. 2011 Jul;18(7):2093-2103.
53. Xia F, Lee CW, Altieri DC. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 2008 Mar 15;68(6):1826-1833.
54. Nishi K, Yoshida M, Fujiwara D, Nishikawa M, Horinou-chi S, Beppu T. Leptomycin B targets a regulatory cascade of crm1, a fssion yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J Biol Chem. 1994 Mar 4;269(9):6320-6324.
55. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B, Yoshida M, Horinouchi S. Leptomycin B inactivates CRM1/exportin 1 by covalent modifcation at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9112-9117.
56. Roberts BJ, Hamelehle KL, Sebolt JS, Leopold WR. In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721). Cancer Chemother Pharmacol. 1986;16(2):95-101.
57. Newlands ES, Rustin GJ, Brampton MH. Phase I trial of elactocin. Br J Cancer. 1996 Aug;74(4):648-649.
58. Naniwa J, Kigawa J, Akeshima R, Kanamori Y, Itamo-chi H, Oishi T, Iba T, Terakawa N. Leptomycin B enhances CDDP-sensitivity via nuclear accumulation of p53 protein in HPV-positive cells. Cancer Sci. 2003 Dec;94(12):1099-1103.
59. Gray LJ, Bjelogrlic P, Appleyard VC, Thompson AM, Jolly CE, Lain S, Herrington CS. Selective induction of apoptosis by leptomycin B in keratinocytes expressing HPV oncogenes. Int J Cancer. 2007 Jun 1;120(11):2317-2324.
60. Mutka SC, Yang WQ, Dong SD, Ward SL, Craig DA, Timmermans PB, Murli S. Identifcation of nuclear export inhibitors with potent anticancer activity in vivo. Cancer Res. 2009 Jan 15;69(2):510-517.
61. Van NT, Pannecouque C, Vanstreels E, Stevens M, De-haen W, Daelemans D. Inhibition of the CRM1-medi-ated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action. Bioorg Med Chem. 2008 Nov 1;16(21):9487-9497.
62. Aronov O, Horowitz AT, Gabizon A, Fuertes MA, Perez JM, Gibson D. Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues. Bio-conjug Chem. 2004 Jul;15(4):814-823.
63. Chahine MN, Pierce GN. Therapeutic targeting of nuclear protein import in pathological cell conditions. Pharmacol Rev. 2009 Sep;61(3):358-372.
64. Camp ER, Li J, Minnich DJ, Brank A, Moldawer LL, MacKay SL, Hochwald SN. Inducible nuclear factor-kap-paB activation contributes to chemotherapy resistance in gastric cancer. J Am Coll Surg. 2004 Aug;199(2):249-258.
65. Huang WC, Chen YJ, Li LY, Wei YL, Hsu SC, Tsai SL, Chiu PC, Huang WP, Wang YN, Chen CH, Chang WC, Chang WC, Chen AJ, Tsai CH, Hung MC. Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in geftinib-resistant cells. J Biol Chem. 2011 Jun 10;286(23):20558-20568.
66. Felsher DW. MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms. Genes Cancer. 2010 Jun;1(6):597-604.
67. Soucek L, Whitfeld J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, Karnezis AN, Brown Swigart L, Nasi S, Evan GI. Modelling Myc inhibition as a cancer therapy. Nature. 2008 Oct 2;455(7213):679-683.
68. Yoneda Y, Imamoto-Sonobe N, Yamaizumi M, Uchida T. Reversible inhibition of protein import into the nucleus by wheat germ agglutinin injected into cultured cells. Exp Cell Res. 1987 Dec;173(2):586-595.
69. Finlay DR, Newmeyer DD, Price TM, Forbes DJ. Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores. J Cell Biol. 1987 Feb;104(2):189-200.
70. Kosugi S, Hasebe M, Entani T, Takayama S, Tomita M, Yanagawa H. Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profling. Chem Biol. 2008 Sep 22;15(9):940-949.
71. Cansizoglu AE, Lee BJ, Zhang ZC, Fontoura BM, Chook YM. Structure-based design of a pathway-spe-cifc nuclear import inhibitor. Nat Struct Mol Biol. 2007 May;14(5):452-454.
72. Ambrus G, Whitby LR, Singer EL, Trott O, Choi E, Olson AJ, Boger DL, Gerace L. Small molecule peptidomi-metic inhibitors of importin alpha/beta mediated nuclear transport. Bioorg Med Chem. 2010 Nov 1;18(21):7611-7620.
73. Wagstaff KM, Rawlinson SM, Hearps AC, Jans DA. An AlphaScreen(R)-based assay for high-throughput screening for specifc inhibitors of nuclear import. J Biomol Screen. 2011 Feb;16(2):192-200.
74. Hintersteiner M, Ambrus G, Bednenko J, Schmied M, Knox AJ, Meisner NC, Gstach H, Seifert JM, Singer EL, Gerace L, Auer M. Identifcation of a small molecule inhibitor of importin beta mediated nuclear import by confocal on-bead screening of tagged one-bead one-compound libraries. ACS Chem Biol. 2010 Oct 15;5(10):967-79.